High-Sensitivity Flow Cytometry for the Reliable Detection of Measurable Residual Disease in Hematological Malignancies in Clinical Laboratories
Background: Monitoring of measurable residual disease (MRD) requires highly sensitive flow cytometry protocols to provide an accurate prediction of shorter progression-free survival. High assay sensitivity generally requires rapid processing to avoid cell loss from small bone marrow sample volumes,...
Saved in:
| Main Authors: | María Beatriz Álvarez Flores, María Sopeña Corvinos, Raquel Guillén Santos, Fernando Cava Valenciano |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Diseases |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-9721/12/12/338 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effect of Atorvastatin on Oncogenic miRNAs in Hematological Malignancies: A Central Study
by: Jood Hashem, et al.
Published: (2024-12-01) -
The Role of Machine Learning in the Most Common Hematological Malignancies: A Narrative Review
by: Teresa Perillo, et al.
Published: (2024-09-01) -
Application of mass cytometry to characterize hematopoietic stem cells in apheresis products of patients with hematological malignancies
by: Carlos Agustin Villegas-Valverde, et al.
Published: (2024-12-01) -
CLINICAL ANALYSIS AND OPTIMIZATION OF POST-REMISSION THERAPY FOR ACUTE MYELOID LEUKEMIA PATIENTS WITH MINIMAL RESIDUAL DISEASE AS DETERMINED BY FLOW CYTOMETRY
by: Hayato Maruoka, et al.
Published: (2010-05-01) -
CLINICAL ANALYSIS AND OPTIMIZATION OF POST-REMISSION THERAPY FOR ACUTE MYELOID LEUKEMIA PATIENTS WITH MINIMAL RESIDUAL DISEASE AS DETERMINED BY FLOW CYTOMETRY
by: Daichi Inoue, et al.
Published: (2010-08-01)